Siemens Healthineers (OTCMKTS:SMMNY) Issues Quarterly Earnings Results

Siemens Healthineers (OTCMKTS:SMMNY) issued its earnings results on Thursday. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.02, Zacks reports. The company had revenue of $6.68 billion during the quarter, compared to analysts’ expectations of $6.96 billion.

Siemens Healthineers Stock Performance

Shares of Siemens Healthineers stock traded down $0.07 during trading hours on Friday, hitting $19.84. The company’s stock had a trading volume of 147,758 shares, compared to its average volume of 169,811. Siemens Healthineers has a twelve month low of $19.54 and a twelve month high of $28.92. The firm has a fifty day moving average of $21.90 and a 200-day moving average of $24.41.

Analyst Ratings Changes

Several brokerages have issued reports on SMMNY. Sanford C. Bernstein upgraded Siemens Healthineers to a “strong-buy” rating in a report on Tuesday, January 13th. Zacks Research upgraded Siemens Healthineers from a “strong sell” rating to a “hold” rating in a report on Monday, January 12th. Finally, Citigroup reiterated a “buy” rating on shares of Siemens Healthineers in a report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Siemens Healthineers currently has a consensus rating of “Buy”.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.